102 related articles for article (PubMed ID: 24369190)
1. Prediction of extracapsular disease with multiparametric magnetic resonance imaging in high risk localized prostate cancer patient.
Hernández-Sánchez JE; Castillo E; Barbero JM; Lista F; Gonzalez J
Arch Esp Urol; 2013 Dec; 66(10):956-66. PubMed ID: 24369190
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer.
Feng TS; Sharif-Afshar AR; Smith SC; Miller J; Nguyen C; Li Q; Luthringer D; Li D; Saouaf R; Kim HL
Urol Oncol; 2015 Mar; 33(3):109.e15-22. PubMed ID: 25512160
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
Dominguez C; Plata M; Cataño JG; Palau M; Aguirre D; Narvaez J; Trujillo S; Gómez F; Trujillo CG; Caicedo JI; Medina C
Int Braz J Urol; 2018; 44(4):688-696. PubMed ID: 29570254
[TBL] [Abstract][Full Text] [Related]
8. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
[TBL] [Abstract][Full Text] [Related]
9. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
11. Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy.
Panebianco V; Salciccia S; Cattarino S; Minisola F; Gentilucci A; Alfarone A; Ricciuti GP; Marcantonio A; Lisi D; Gentile V; Passariello R; Sciarra A
J Sex Med; 2012 Aug; 9(8):2157-66. PubMed ID: 22642466
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.
Thompson JE; van Leeuwen PJ; Moses D; Shnier R; Brenner P; Delprado W; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
J Urol; 2016 May; 195(5):1428-1435. PubMed ID: 26529298
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy.
Hattori S; Kosaka T; Mizuno R; Kanao K; Miyajima A; Yasumizu Y; Yazawa S; Nagata H; Kikuchi E; Mikami S; Jinzaki M; Nakagawa K; Tanimoto A; Oya M
BJU Int; 2014 May; 113(5):741-7. PubMed ID: 23937660
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?
Porpiglia F; Cantiello F; De Luca S; De Pascale A; Manfredi M; Mele F; Bollito E; Cirillo S; Damiano R; Russo F
Int J Urol; 2016 Sep; 23(9):752-7. PubMed ID: 27277398
[TBL] [Abstract][Full Text] [Related]
15. [Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].
de Vendin C; Eydant Y; Ecochard R; Lorin S; Lacroix B; Lardon R; Mottet N
Prog Urol; 2013 Dec; 23(16):1412-8. PubMed ID: 24274946
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
[TBL] [Abstract][Full Text] [Related]
18. Gleason Score within Prostate Abnormal Areas Defined by Multiparametric Magnetic Resonance Imaging Did Not Vary According to the PIRADS Score.
Slaoui H; Neuzillet Y; Ghoneim T; Rouanne M; Abdou A; Lugagne-Delpon PM; Scherrer A; Radulescu C; Delancourt C; Molinié V; Lebret T
Urol Int; 2017; 99(2):156-161. PubMed ID: 28391284
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
20. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
